http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1174882-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 1968-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_389ab7960fa866c4aa38a4b074c58253
publicationDate 1969-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1174882-A
titleOfInvention Opthalmic Compositions
abstract 1,174,882. Ophthalmic compositions. MERCK & CO. Inc. 12 March, 1968 [16 March, 1967], No. 11980/68 Heading ASB. An anti-glaucoma topical ophthalmic composition comprises 10, 11-dihydro-5-(3-dimethylaminopropyl)-5, 10-epoxy-11-hydroxyimino- 5H-dibenzo [a, d]-cycloheptene or trans 10, 11- dihydro-5-(3-methylaminopropyl)-5, 10-epoxy- 11-hydroxy-5H-dibenzo [a, d] cycloheptene, or their non-toxic acid addition salts (e.g. hydrochloride or hydrogen maleate), together with a conventional topical ophthalmic ointment or a topical ophthalmic buffered isotonic aqueous solution containing a preservative. The compositions may also contain an exogenous sympathomimetic amine (e.g. epinephrine, norepinephrine or isoproterenol), 8-hydroxyquinolone sulphate, sodium bisulphite, phenylmercuric acetate and boric acid and/or sodium borate.
priorityDate 1967-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544741
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419575175
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7628
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432440536
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453104438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447980235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3779
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5814
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16682730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425165937
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549087
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5816
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448616730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448977888
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154349076
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161148805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11966254
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407182981
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19704689
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503910
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313

Total number of triples: 41.